Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Pro Dex (PDEX) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn
10	Pro Dex	201.21 Mn	193.60 Mn	6.13 Mn

Historic Data

Download Data 🔒

Date	Value
Mar 31, 2026	83.58%
Dec 31, 2025	-53.15%
Sep 30, 2025	286.49%
Jun 30, 2025	-63.00%
Mar 31, 2025	58.73%
Dec 31, 2024	-17.11%
Sep 30, 2024	65.22%
Jun 30, 2024	142.11%
Mar 31, 2024	35.71%
Dec 31, 2023	182.35%
Sep 30, 2023	-140.48%
Jun 30, 2023	-8.70%
Mar 31, 2023	-40.26%
Dec 31, 2022	133.33%
Sep 30, 2022	-35.29%
Jun 30, 2022	218.75%
Mar 31, 2022	-46.67%
Dec 31, 2021	0.00%
Sep 30, 2021	3.45%
Jun 30, 2021	-49.12%
Mar 31, 2021	23.91%
Dec 31, 2020	58.62%
Sep 30, 2020	-56.06%
Jun 30, 2020	112.90%
Mar 31, 2020	-3.13%
Dec 31, 2019	14.29%
Dec 31, 2016	1,028.57%
Sep 30, 2016	40.00%
Jun 30, 2016	-44.44%
Mar 31, 2016	-18.18%
Dec 31, 2015	466.67%
Mar 31, 2015	60.00%
Dec 31, 2014	-25.00%
Sep 30, 2014	-76.87%
Jun 30, 2014	81.15%
Mar 31, 2014	-20.00%
Dec 31, 2013	-266.67%
Sep 30, 2013	127.27%
Jun 30, 2013	4.35%
Mar 31, 2013	-109.09%
Dec 31, 2012	-450.00%
Sep 30, 2012	88.24%
Jun 30, 2012	0.00%
Mar 31, 2012	-88.89%
Dec 31, 2011	-164.29%
Sep 30, 2011	-56.25%
Jun 30, 2011	14.29%
Mar 31, 2011	133.33%
Dec 31, 2010	9.09%